This topic contains a solution. Click here to go to the answer

Author Question: The client has been started on valproic acid. Her level of the medication is drawn and is found to ... (Read 27 times)

P68T

  • Hero Member
  • *****
  • Posts: 509
The client has been started on valproic acid. Her level of the medication is drawn and is found to be 60 mcg/mL. The nurse notes that this is a(n) _____ level.
 
  a. toxic
  b. therapeutic
  c. subnormal
  d. above-normal

Question 2

The client has been started on phenytoin and reports to the nurse that he also takes ginkgo. What is the most accurate response from the nurse?
 
  a. Ginkgo can decrease the effectiveness of phenytoin.
  b. Ginkgo can increase the effectiveness of phenytoin.
  c. Ginkgo can cause an anaphylactic reaction to phenytoin.
  d. Ginkgo can cause phenytoin to reach a toxic level.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

parker125

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

ANS: B
60 mcg/mL is a therapeutic level of valproic acid.

Answer to Question 2

ANS: A
Ginkgo can cause phenytoin to be less effective than normal.




P68T

  • Member
  • Posts: 509
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


Jsherida

  • Member
  • Posts: 314
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

The horizontal fraction bar was introduced by the Arabs.

Did you know?

Most women experience menopause in their 50s. However, in 1994, an Italian woman gave birth to a baby boy when she was 61 years old.

Did you know?

Acute bronchitis is an inflammation of the breathing tubes (bronchi), which causes increased mucus production and other changes. It is usually caused by bacteria or viruses, can be serious in people who have pulmonary or cardiac diseases, and can lead to pneumonia.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library